Show simple item record

dc.contributor.authorNoteboom, Ben
dc.contributor.authorJenkins, Susan
dc.contributor.authorMaiorana, Andrew
dc.contributor.authorCecins, Nola
dc.contributor.authorNg, C.
dc.contributor.authorHill, Kylie
dc.date.accessioned2017-01-30T11:50:38Z
dc.date.available2017-01-30T11:50:38Z
dc.date.created2014-06-16T20:00:16Z
dc.date.issued2014
dc.identifier.citationNoteboom, B. and Jenkins, S. and Maiorana, A. and Cecins, N. and Ng, C. and Hill, K. 2014. Comorbidities and Medication Burden in Patients with Chronic Obstructive Pulmonary Disease Attending Pulmonary Rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention. 34 (1): pp. 75-79.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/15578
dc.identifier.doi10.1097/HCR.0000000000000036
dc.description.abstract

PURPOSE: Chronic obstructive pulmonary disease (COPD) is characterized by concomitant systemic manifestations and comorbidities such as cardiovascular disease. Little data exist on the prevalence of comorbidities and medication burden in people with COPD attending pulmonary rehabilitation (PR) programs in Australia. This study aimed to determine the prevalence of comorbidities and describe the type and number of medications reported in a sample of patients with COPD referred to PR. METHODS: A retrospective audit was conducted on patients referred to PR over a 1-year period. Data were collected on patient demographics, disease severity, comorbidities, and medications by review of patient notes, physician referral, and self-reported medication use. RESULTS: Data were available on 70 patients (forced expiratory volume in 1 second = 37.5 [26.0] % predicted). Ninety-six percent of patients had at least 1 comorbidity, and 29% had 5 or more. The most common comorbidities were associated with cardiovascular disease (64% of patients). Almost half of the sample was overweight or obese (49%). Prescription medication use was high, with 57% using between 4 and 7 medications, and 29% using 8 or more. CONCLUSIONS: Patients with COPD attending PR in Australia have high rates of comorbidity. The number of medications prescribed for these individuals is similar to that seen in other chronic disease states such as chronic heart failure. Pulmonary rehabilitation presents opportunities for clinicians to educate patients on self-management strategies for multiple comorbidities, review medication usage, and discuss strategies aimed at optimizing adherence with medication regimes.

dc.publisherLippincott Williams & Wilkins
dc.subjectpulmonary rehabilitation
dc.subjectcomorbidity
dc.subjectpolypharmacy
dc.subjectchronic obstructive pulmonary disease
dc.titleComorbidities and Medication Burden in Patients with Chronic Obstructive Pulmonary Disease Attending Pulmonary Rehabilitation
dc.typeJournal Article
dcterms.source.volume34
dcterms.source.number1
dcterms.source.startPage75
dcterms.source.endPage79
dcterms.source.issn19327501
dcterms.source.titleJournal of Cardiopulmonary Rehabilitation and Prevention
curtin.department
curtin.accessStatusFulltext not available


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record